The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35HvdwQ
No comments:
Post a Comment